Indonesia has approved Sinovac Biotech's COVID-19 vaccine for use in elderly people after receiving clinical trial results from China and Brazil at the end of January, as reported MSN on Sunday.
According to Penny Lukito, head of Indonesia’s food and drug regulator, the trials showed no reports of serious side effects on the use of the vaccine.
The first and second phase of trials of the vaccine in China that involved 400 elderly participants showed good results of increased amount of antibodies, she said on Sunday.
The Phase III trial in Brazil, which included 600 people aged 59 to 70, showed mild effects such as headaches, Lukito said.
"The death rate because of the COVID-19 virus is relatively high for the elderly, so we need to also give priority for the elderly to get vaccinated," she added.
To read more NewsPoints articles, click here.